BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Clinical Outcome
11 results:

  • 1. High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.
    Pratt D; Abdullaev Z; Papanicolau-Sengos A; Ketchum C; Panneer Selvam P; Chung HJ; Lee I; Raffeld M; Gilbert MR; Armstrong TS; Pytel P; Borys E; Klonoski JM; McCord M; Horbinski C; Brat D; Perry A; Solomon D; Eberhart C; Giannini C; Quezado M; Aldape K
    Acta Neuropathol; 2022 Mar; 143(3):403-414. PubMed ID: 35103816
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary mismatch repair deficient IDH-mutant astrocytoma (PMMRDIA) is a distinct type with a poor prognosis.
    Suwala AK; Stichel D; Schrimpf D; Kloor M; Wefers AK; Reinhardt A; Maas SLN; Kratz CP; Schweizer L; Hasselblatt M; Snuderl M; Abedalthagafi MSJ; Abdullaev Z; Monoranu CM; Bergmann M; Pekrun A; Freyschlag C; Aronica E; Kramm CM; Hinz F; Sievers P; Korshunov A; Kool M; Pfister SM; Sturm D; Jones DTW; Wick W; Unterberg A; Hartmann C; Dodgshun A; Tabori U; Wesseling P; Sahm F; von Deimling A; Reuss DE
    Acta Neuropathol; 2021 Jan; 141(1):85-100. PubMed ID: 33216206
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Randomized Phase II Study of Paclitaxel plus Alisertib versus Paclitaxel plus Placebo as Second-Line Therapy for SCLC: Primary and Correlative Biomarker Analyses.
    Owonikoko TK; Niu H; Nackaerts K; Csoszi T; Ostoros G; Mark Z; Baik C; Joy AA; Chouaid C; Jaime JC; Kolek V; Majem M; Roubec J; Santos ES; Chiang AC; Speranza G; Belani CP; Chiappori A; Patel MR; Czebe K; Byers L; Bahamon B; Li C; Sheldon-Waniga E; Kong EF; Williams M; Badola S; Shin H; Bedford L; Ecsedy JA; Bryant M; Jones S; Simmons J; Leonard EJ; Ullmann CD; Spigel DR;
    J Thorac Oncol; 2020 Feb; 15(2):274-287. PubMed ID: 31655296
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas.
    Sutter R; Shakhova O; Bhagat H; Behesti H; Sutter C; Penkar S; Santuccione A; Bernays R; Heppner FL; Schüller U; Grotzer M; Moch H; Schraml P; Marino S
    Oncogene; 2010 Mar; 29(12):1845-56. PubMed ID: 20062081
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cytogenetic analyses in 81 patients with brain gliomas: correlation with clinical outcome and morphological data.
    Kramar F; Zemanova Z; Michalova K; Babicka L; Ransdorfova S; Hrabal P; Kozler P
    J Neurooncol; 2007 Sep; 84(2):201-11. PubMed ID: 17569001
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic factors for anaplastic astrocytomas.
    Compostella A; Tosoni A; Blatt V; Franceschi E; Brandes AA
    J Neurooncol; 2007 Feb; 81(3):295-303. PubMed ID: 17001519
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma.
    Michalowski MB; de Fraipont F; Michelland S; Entz-Werle N; Grill J; Pasquier B; Favrot MC; Plantaz D
    Cancer Genet Cytogenet; 2006 Apr; 166(1):74-81. PubMed ID: 16616114
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Subependymal giant cell astrocytoma: a clinicopathological study of 23 cases with special emphasis on proliferative markers and expression of p53 and retinoblastoma gene proteins.
    Sharma M; Ralte A; Arora R; Santosh V; Shankar SK; Sarkar C
    Pathology; 2004 Apr; 36(2):139-44. PubMed ID: 15203749
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Frequent alterations of cell-cycle regulators in astrocytic tumors as detected by molecular genetic and immunohistochemical analyses.
    Nakamura M; Konishi N; Hiasa Y; Tsunoda S; Nakase H; Tsuzuki T; Aoki H; Sakitani H; Inui T; Sakaki T
    Brain Tumor Pathol; 1998; 15(2):83-8. PubMed ID: 10328544
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.
    Newcomb EW; Cohen H; Lee SR; Bhalla SK; Bloom J; Hayes RL; Miller DC
    Brain Pathol; 1998 Oct; 8(4):655-67. PubMed ID: 9804374
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study.
    Rieger L; Weller M; Bornemann A; Schabet M; Dichgans J; Meyermann R
    J Neurol Sci; 1998 Feb; 155(1):68-75. PubMed ID: 9562325
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.